AU Stock MarketDetailed Quotes

ILAO Island Pharmaceuticals Ltd

Watchlist

0.026
0.0000.00%

20min DelayMarket Closed Sep 11 15:28 AET

3.30MMarket Cap0.00P/E (Static)

Island Pharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2024

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

Operating cash flow (direct method)

Cash income from operating activities

Cash paid

-31.55%-3.57M

-44.37%-2.71M

-100.12%-1.88M

-938.24K

Payments to suppliers for goods and services

-31.55%-3.57M

-44.37%-2.71M

-100.12%-1.88M

---938.24K

Direct interest received

-57.40%4.71K

--11.07K

----

----

Direct tax refund paid

--396.35K

----

----

----

Operating cash flow

-17.23%-3.16M

-43.78%-2.7M

-100.12%-1.88M

---938.24K

Investing cash flow

Cash flow from continuing investing activities

77.37K

Net business purchase and sale

----

----

----

--77.37K

Cash from discontinued investing activities

Investing cash flow

----

----

----

--77.37K

Financing cash flow

Cash flow from continuing financing activities

1,645.03%2.79M

-180.36K

7.3M

Net issuance payments of debt

215.90%198.6K

---171.36K

----

----

Net common stock issuance

--2.6M

----

----

--7.28M

Interest paid (cash flow from financing activities)

-8.48%-9.76K

---9K

----

----

Net other financing activities

----

----

----

--19.95K

Cash from discontinued financing activities

Financing cash flow

1,645.03%2.79M

---180.36K

----

--7.3M

Net cash flow

Beginning cash position

-58.26%2M

-25.90%4.79M

646,064,300.00%6.46M

--1

Current changes in cash

86.86%-378.38K

-53.39%-2.88M

-129.17%-1.88M

--6.44M

Effect of exchange rate changes

-55.47%40.5K

-55.51%90.94K

770.70%204.43K

--23.48K

End cash Position

-16.91%1.66M

-58.26%2M

-25.90%4.79M

--6.46M

Free cash from

-17.23%-3.16M

-43.78%-2.7M

-100.12%-1.88M

---938.24K

Accounting Standards

US-GAAP

US-GAAP

US-GAAP

US-GAAP

	(FY)Jun 30, 2024	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021
Operating cash flow (direct method)
Cash income from operating activities
Cash paid	-31.55%-3.57M	-44.37%-2.71M	-100.12%-1.88M	-938.24K
Payments to suppliers for goods and services	-31.55%-3.57M	-44.37%-2.71M	-100.12%-1.88M	---938.24K
Direct interest received	-57.40%4.71K	--11.07K	----	----
Direct tax refund paid	--396.35K	----	----	----
Operating cash flow	-17.23%-3.16M	-43.78%-2.7M	-100.12%-1.88M	---938.24K
Investing cash flow
Cash flow from continuing investing activities				77.37K
Net business purchase and sale	----	----	----	--77.37K
Cash from discontinued investing activities
Investing cash flow	----	----	----	--77.37K
Financing cash flow
Cash flow from continuing financing activities	1,645.03%2.79M	-180.36K		7.3M
Net issuance payments of debt	215.90%198.6K	---171.36K	----	----
Net common stock issuance	--2.6M	----	----	--7.28M
Interest paid (cash flow from financing activities)	-8.48%-9.76K	---9K	----	----
Net other financing activities	----	----	----	--19.95K
Cash from discontinued financing activities
Financing cash flow	1,645.03%2.79M	---180.36K	----	--7.3M
Net cash flow
Beginning cash position	-58.26%2M	-25.90%4.79M	646,064,300.00%6.46M	--1
Current changes in cash	86.86%-378.38K	-53.39%-2.88M	-129.17%-1.88M	--6.44M
Effect of exchange rate changes	-55.47%40.5K	-55.51%90.94K	770.70%204.43K	--23.48K
End cash Position	-16.91%1.66M	-58.26%2M	-25.90%4.79M	--6.46M
Free cash from	-17.23%-3.16M	-43.78%-2.7M	-100.12%-1.88M	---938.24K
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

AU

Overall

No Data